NCT04590118View on ClinicalTrials.gov

Allogeneic Mesenchymal Stem Cells for the Survivors of Ischemic Stroke Trial (ASSIST)

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 26, 2021

Primary Completion Date

April 1, 2023

Study Completion Date

August 1, 2023

Conditions
Ischemic Stroke
Interventions
DRUG

it-hMSC

Single intravenous infusion of it-hMSC for ischemic stroke patients

DRUG

Placebo

Single intravenous infusion of 1 ml/kg placebo

Trial Locations (1)

100070

RECRUITING

Beijing Tiantan Hospital, Capital Medical University, Beijing

Sponsors
All Listed Sponsors
collaborator

Beijing Tiantan Hospital

OTHER

lead

Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd.

OTHER

NCT04590118 - Allogeneic Mesenchymal Stem Cells for the Survivors of Ischemic Stroke Trial (ASSIST) | Biotech Hunter | Biotech Hunter